GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Consort Medical PLC (GREY:CSRMY) » Definitions » 5-Year EBITDA Growth Rate

Consort Medical (Consort Medical) 5-Year EBITDA Growth Rate : 0.00% (As of Oct. 2019)


View and export this data going back to . Start your Free Trial

What is Consort Medical 5-Year EBITDA Growth Rate?

Consort Medical's EBITDA per Share for the six months ended in Oct. 2019 was $0.42.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Competitive Comparison of Consort Medical's 5-Year EBITDA Growth Rate

For the Medical Instruments & Supplies subindustry, Consort Medical's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Consort Medical's 5-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Consort Medical's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Consort Medical's 5-Year EBITDA Growth Rate falls into.



Consort Medical 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Consort Medical  (GREY:CSRMY) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.


Consort Medical 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Consort Medical's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Consort Medical (Consort Medical) Business Description

Traded in Other Exchanges
N/A
Address
Breakspear Way, Suite B Breakspear Park, Hemel Hempstead, Hertfordshire, GBR, HP2 4TZ
Consort Medical PLC is part of the healthcare sector in the United Kingdom. It is one of the leading contract manufacturers in the field of drug delivery devices. Its core products include an inhaler, auto-injector, nasal and ocular technologies which it supplies to pharmaceutical companies. Along with devices, the company also specializes in drugs including active pharmaceutical ingredients and finished dose formulations.

Consort Medical (Consort Medical) Headlines

No Headlines